Last reviewed · How we verify
NCT05517681
Application of ICG in Lymph Node Dissection During Radical Resection of Rectal Cancer With Preserved Autonomic Nerves Around LCA and IMA
NA trial testing non-ICG in Indocyanine Green in 96 participants. Completed in 10 July 2022.
10 July 2022
Quick facts
| Lead sponsor | The First Hospital of Qinhuangdao |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 96 |
| Start date | 7 September 2020 |
| Primary completion | 10 July 2022 |
| Estimated completion | 10 July 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- non-ICG
- ICG — full drug profile →
Conditions studied
- Indocyanine Green — all drugs for Indocyanine Green →
Sponsor
The First Hospital of Qinhuangdao
Who can join
Adults 40 to 80, any sex, with Indocyanine Green. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Indocyanine green NIR imaging is valuable for lymph node dissection in D3 radical surgery for rectal cancer. It can guide the intraoperative improvement of lymph node dissection based on the preservation of LCA and peripheral autonomic nerves of IMA. This not only reduces the occurrence of postoperative complications and promotes rapid postoperative recovery, but also provides a more precise and individualized comprehensive treatment plan for patients after surgery. In addition，this trial also demonstrated that ICG is safe and feasible for use in rectal cancer
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05517681
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Indocyanine Green
Currently open trials in the same condition.
- NCT06302985 — Atomized Inhalation ICG for Treatment of Congenital Lung Malformations · NA · recruiting
- NCT07181070 — The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor · recruiting
Other The First Hospital of Qinhuangdao trials
Trials by the same sponsor.
- NCT06598852 — To Compare the Analgesic Effects of Different Nerve Block Analgesia Methods in Thoracoscopic Surgery · NA · recruiting
- NCT06684210 — Study of the Clinical Effect of External Oblique Muscle Intercostal Muscle Plane Block in Abdominal Surgery · NA · completed
- NCT05739318 — the Diameter of Double-lumen Tube Measured by Different Methods · NA · completed
- NCT05364216 — Effect of TPVB on Postoperative Pain and Cognitive Function After VATS in Elderly Patients · NA · completed
- NCT05331287 — Comparing the "Snifing Position" , "Simple Head Extension" and "Neutral Position" · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05517681 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Hospital of Qinhuangdao
- Last refreshed: 26 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517681.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing